Marker Therapeutics Inc
NASDAQ:MRKR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
|
Grifols SA
OTC:GIKLY
|
ES |
|
A
|
AT&T Inc
XMUN:SOBA
|
US |
|
Capcom Co Ltd
F:CPK0
|
JP |
|
H
|
HCA Healthcare Inc
XMUN:2BH
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
DUS:ME9
|
IT |
|
B
|
BP PLC
XMUN:BPE5
|
UK |
|
Daikin Industries Ltd
F:DKIA
|
JP |
|
Aena SME SA
F:A440
|
ES |
|
S
|
Spire Inc
F:LGR
|
US |
|
Publicis Groupe SA
F:PU41
|
FR |
|
H
|
HCA Healthcare Inc
F:2BH
|
US |
|
E
|
ESCO Technologies Inc
F:ET7
|
US |
|
A
|
Altria Group Inc
XMUN:PHM7
|
US |
|
T
|
thyssenkrupp AG
XMUN:TKA1
|
DE |
Intrinsic Value
The intrinsic value for
Marker Therapeutics Inc (MRKR) under the Base Case is hidden
USD.
Compared with the current market price of 1.24 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
MRKR looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with MRKR’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
Revenue & Expenses Breakdown
Marker Therapeutics Inc
Earnings Waterfall
Marker Therapeutics Inc
The intrinsic value for
Marker Therapeutics Inc (MRKR) under the Base Case is hidden USD.
Compared with the current market price of 1.24 USD, the stock appears hidden.